학술논문
Bispecific antibodies increase the therapeutic window of CD40 agonists through selective dendritic cell targeting
Document Type
Article
Author
Source
In: Nature Cancer . (Nature Cancer, March 2022, 3(3):287-302)
Subject
Language
English
ISSN
26621347